Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | serine:threonine protein kinase Chk2 | 0.0037 | 0.0000091267 | 0.0001 |
Mycobacterium tuberculosis | Probable dihydroorotate dehydrogenase PyrD | 0.0509 | 0.2935 | 0.5 |
Plasmodium vivax | dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0509 | 0.2935 | 1 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0449 | 0.2564 | 0.8077 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0199 | 0.1006 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0199 | 0.1006 | 0.5 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0199 | 0.1006 | 0.5 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0199 | 0.1006 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0199 | 0.1006 | 0.5 |
Trypanosoma brucei | dihydroorotate dehydrogenase (fumarate) | 0.0509 | 0.2935 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0509 | 0.2935 | 1 |
Brugia malayi | Telomerase reverse transcriptase | 0.1195 | 0.7206 | 1 |
Mycobacterium ulcerans | dihydroorotate dehydrogenase 2 | 0.0509 | 0.2935 | 0.5 |
Brugia malayi | Dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0509 | 0.2935 | 0.3112 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0449 | 0.2564 | 0.8077 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0199 | 0.1006 | 0.5 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0199 | 0.1006 | 0.5 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0509 | 0.2935 | 1 |
Trichomonas vaginalis | dihydropyrimidine dehydrogenase, putative | 0.0199 | 0.1006 | 0.5 |
Entamoeba histolytica | dihydropyrimidine dehydrogenase, putative | 0.0199 | 0.1006 | 1 |
Mycobacterium leprae | Probable dihydroorotate dehydrogenase PyrD | 0.0509 | 0.2935 | 0.5 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0199 | 0.1006 | 1 |
Plasmodium falciparum | dihydroorotate dehydrogenase | 0.0509 | 0.2935 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase (fumarate), putative | 0.0509 | 0.2935 | 1 |
Schistosoma mansoni | dihydroorotate dehydrogenase | 0.0509 | 0.2935 | 1 |
Toxoplasma gondii | dihydroorotate dehydrogenase reveal, putative | 0.0509 | 0.2935 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydroorotate dehydrogenase 2 | 0.0509 | 0.2935 | 0.5 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0199 | 0.1006 | 1 |
Brugia malayi | Dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0509 | 0.2935 | 0.3112 |
Leishmania major | dihydroorotate dehydrogenase | 0.0509 | 0.2935 | 1 |
Giardia lamblia | Telomerase catalytic subunit | 0.0449 | 0.2564 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase Chk2 | 0.0037 | 0.0000091267 | 0.0001 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.